Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
Holding DE:9IP1?
Track your performance easily

Rocket Pharmaceuticals (9IP1) Financial Statements

1 Followers

Rocket Pharmaceuticals Financial Overview

Rocket Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Rocket Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is €-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit$ -600.00K$ -800.00K$ -600.00K$ -700.00K$ -500.00K
EBIT$ -66.25M$ -69.17M$ -61.58M$ -61.43M$ -65.23M
EBITDA$ -64.40M$ -67.34M$ -59.87M$ -59.67M$ -64.04M
Net Income Common Stockholders$ -66.72M$ -69.65M$ -62.05M$ -61.90M$ -65.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 235.66M$ 278.82M$ 330.31M$ 437.17M$ 307.04M
Total Assets$ 393.69M$ 446.41M$ 499.44M$ 598.76M$ 461.78M
Total Debt$ 25.64M$ 25.80M$ 25.95M$ 25.18M$ 25.39M
Net Debt$ -210.02M$ -253.03M$ -304.36M$ -411.99M$ -281.65M
Total Liabilities$ 63.92M$ 61.78M$ 57.94M$ 57.68M$ 58.81M
Stockholders Equity$ 329.77M$ 384.63M$ 441.50M$ 541.09M$ 402.97M
Cash Flow-
Free Cash Flow$ -53.69M$ -55.75M$ -58.89M$ -61.80M$ -54.98M
Operating Cash Flow$ -52.10M$ -53.82M$ -56.86M$ -57.15M$ -50.87M
Investing Cash Flow$ 78.92M$ 55.62M$ 35.03M$ 48.25M$ 31.21M
Financing Cash Flow$ 176.00K$ 1.53M$ 1.18M$ 189.49M$ 182.00K
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

Rocket Pharmaceuticals Debt to Assets

Rocket Pharmaceuticals Cash Flow

Rocket Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis